Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC

Cancer Immunology Immunotherapy(2021)10.1007/s00262-020-02792-5Source: DataRank Database

Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC is a research paper published in Cancer Immunology Immunotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 77 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access77 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 4.25)OA: greenTopics (50)Linked Datasets (22)DataCite Reuse (22)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Margaret P. Manspeaker ORCID,Susan N. Thomas ORCID,Meghan J. O’Melia ORCID

Live enrichment

PubMed:33459842 PMC:PMC8286278 OpenAlex:https://openalex.org/W3121825884

Susan G. Komen

Grant: CCR15330478

Foundation for the National Institutes of Health

Grant: R01CA207619

Foundation for the National Institutes of Health

Grant: U01CA214354

Foundation for the National Institutes of Health

Grant: T32GM008433

Foundation for the National Institutes of Health

Grant: S10OD016264

National Institutes of Health

Grant: 5U01CA214354-02

Mechanisms of impaired T-cell mechanosensing of melanoma antigens

National Institutes of Health

Grant: 3R01CA207619-03S1

Melanoma immunotherapy targeting sentinel lymph nodes

National Institutes of Health

Grant: 5T32GM008433-29

Cell and Tissue Engineering Training Program

National Institutes of Health

Grant: 1S10OD016264-01A1

IVIS Spectrum in vivo Imaging System

FWCI

4.25

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8286278

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-020-02792-5.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-020-02792-5/fulltext.html

journalhttps://doi.org/10.1007/s00262-020-02792-5

Fields of Study

Immunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersT-cell and B-cell Immunology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Immune Checkpoint InhibitorsAnimalsAntigens, NeoplasmCell SurvivalFemaleImmunotherapyLymph NodesLymphoid TissueMice, Inbred C57BLCD8-Positive T-LymphocytesCell Line, TumorMiceTumor MicroenvironmentTriple Negative Breast Neoplasms

Keywords

Tumor microenvironmentLymphatic systemImmune systemPriming (agriculture)ImmunologyCD8T cellImmunotherapyCytotoxic T cellBiologyAntigenCancer immunotherapyCancer researchLymph nodesDrug DeliveryTriple-negative Breast CancerT Cell PrimingTumor DisseminationImmune Checkpoint BlockadeCell SurvivalLymphoid TissueTriple Negative Breast NeoplasmsCD8-Positive T-LymphocytesMice, Inbred C57BLMiceAntigens, NeoplasmCell Line, TumorAnimalsFemaleImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557049.v1figshare

Additional file 1 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557049figshare

Additional file 2 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557052.v1figshare

Additional file 2 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557052figshare

Additional file 3 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557055.v1figshare

Additional file 3 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557055figshare

Additional file 4 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557058.v1figshare

Additional file 4 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557058figshare

Additional file 5 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557061.v1figshare

Additional file 5 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557061figshare

Additional file 6 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557064.v1figshare

Additional file 6 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557064figshare

Additional file 7 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557067.v1figshare

Additional file 7 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557067figshare

Additional file 8 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557070.v1figshare

Additional file 8 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557070figshare

Additional file 9 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557073.v1figshare

Additional file 9 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

10.6084/m9.figshare.26557073figshare

Additional file 2 of Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment

10.6084/m9.figshare.21443470.v1figshare

Additional file 1 of Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment

10.6084/m9.figshare.21443467figshare

Related Papers (9)

Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy

ACS Nano(2018)

OpenAlex related

10.1021/acsnano.8b05893

Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment

ACS Applied Materials & Interfaces(2020)

OpenAlex related

10.1021/acsami.0c14909

Lymphatic vessels in human adipose tissue

Cell and Tissue Research(2019)

OpenAlex related

10.1007/s00441-019-03108-5

Anatomy of the Lymphatic System and Its Disorders

(2011)

OpenAlex related

10.1007/978-0-85729-567-5_5

Pathophysiology of Lymphedemas with Respect to Surgery

(2016)

OpenAlex related

10.1007/978-3-319-31647-5_1

Drug Delivery to the Lymphatic System

Drug Delivery(2016)

OpenAlex related

10.1002/9781118833322.ch21

Lymphatic System

Encyclopedia of Life Sciences(2009)

OpenAlex related

10.1002/9780470015902.a0000523.pub2

Isolated Human Lymphatic Vessels and Lymphatic Endothelial Cells

Lymphatic Research and Biology(2017)

OpenAlex related

10.1089/lrb.2017.29021.sr

Lymphatic vessels in health and disease

Proceedings for Annual Meeting of The Japanese Pharmacological Society(2020)

OpenAlex related

10.1254/jpssuppl.93.0_1-s05-1